Key drivers for market penetration of biosimilars in Europe
Background & Objectives: Potential drivers and barriers of biosimilar uptake were mainly analysed through qualitative approaches. The study objective was to conduct a quantitative analysis and identify drivers of biosimilar uptake of all available biosimilars in the European Union (EU). Methods:...
Saved in:
Main Authors: | Cécile Rémuzat (Author), Julie Dorey (Author), Olivier Cristeau (Author), Dan Ionescu (Author), Guerric Radière (Author), Mondher Toumi (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2017-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Supply-side and demand-side policies for biosimilars: an overview in 10 European member states
by: Cécile Rémuzat, et al.
Published: (2017) -
Value added medicines: what value repurposed medicines might bring to society?
by: Mondher Toumi, et al.
Published: (2017) -
Proposed changes to the reimbursement of pharmaceuticals and medical devices in Poland and their impact on market access and the pharmaceutical industry
by: Karolina Badora, et al.
Published: (2017) -
Market access agreements for pharmaceuticals in Europe: diversity of approaches and underlying concepts
by: Jarosławski Szymon, et al.
Published: (2011) -
Gene therapies development: slow progress and promising prospect
by: Eve Hanna, et al.
Published: (2017)